Results 201 to 210 of about 52,048 (217)

Efficacy of atypical antipsychotics in the treatment of fecal incontinence in children and adolescents: a randomized clinical trial. [PDF]

BMC Pediatr
Zahed G, Fatahi S, Tabatabaee L, Imanzadeh N, Seraj SS, Wolters BH, Hosseini A.   +6 more
europepmc   +1 more source

Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. [PDF]

CNS Drugs
Lenk HÇ, Smith RL, O'Connell KS, Andreassen OA, Molden E.   +4 more
europepmc   +1 more source

Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis. [PDF]

Eur Psychiatry
Li S, Xu C, Hu S, Lai J.
europepmc   +1 more source

Can atypical antipsychotics alleviate Deficits in psychosocial impairments in patients with a diagnosis of Borderline Personality? A systematic review and meta-analysis.

Psychiatry Res Commun
Griffiths K, Velichkova N, Quadt L, Berni J.   +3 more
europepmc   +1 more source

Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics. [PDF]

J Comp Eff Res
Rajagopalan K, Rashid N, Gopal D, Doshi D.   +3 more
europepmc   +1 more source

An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco. [PDF]

Ann Gen Psychiatry
Tazi A, Errachidi F, Sonawane D, Tahri G, Rao S, Mehta S.   +5 more
europepmc   +1 more source